SEARCH

SEARCH BY CITATION

References

  • 1
    Liermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center. Hepatology 2001; 33:2227.
  • 2
    Neuberger JM. Transplantation for primary biliary cirrhosis. Semin Liver Dis 1997; 17:137146.
  • 3
    Rust C, Rau H, Gerbes AL, Pape GR, Haller M, Kramling H, et al. Liver transplantation in primary biliary cirrhosis: Risk assessment and 11-year follow-up. Digestion 2000; 62:3843.
  • 4
    Neuberger JM, Portmann B, MacDougall BJ, Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982; 306:14.
  • 5
    Knoop M, Bechstein WO, Schrem H, Lobeck H, Hopf U, Neuhaus P. Clinical significance of recurrent primary biliary cirrhosis after liver transplantation. Transplant Int 1996; 9(suppl 1):S115S119.
  • 6
    Dietze O, Vogel W, Margreiter R. Primary biliary cirrhosis after liver transplantation. Transplant Proc 1990; 22:15011502.
  • 7
    Hubscher S, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis: Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18:173184.
  • 8
    Wong PYN, Portmann B, O'Grady J, Devlin JJ, Hegarty JE, Tan KC, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression. J Hepatol 1993; 17:284287.
  • 9
    Hayashi M, Keefe EB, Krams SM, Martinez OM, Ojogho ON, So SK, et al. Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg 1998; 4:208214.
  • 10
    Berlakovich GA, Imhof M, Karner-Hanusch J, Gotzinger P, Gollackner B, Gnant M, et al. The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation. Transplantation 1996; 61:554560.
  • 11
    Balan V, Abu-Elmagd K, Demetris A. Autoimmune liver diseases: Recurrence after liver transplantation. Surg Clin North Am 1999; 79:147152.
  • 12
    Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997; 113:884890.
  • 13
    Papatheodoridis GB, Hadziyannis ES, Deutsch M, Hadziyannis SJ. Ursodeoxycholic acid for primary biliary cirrhosis: Final results of a 12-year, prospective, randomized, controlled trial. Am J Gastroenterol 2002; 97:20632070.
    Direct Link:
  • 14
    Goulis J, Leandro G, Burroughs AK. Randomised controlled trials of ursodeoxycholic acid in primary biliary cirrhosis: A meta-analysis. Lancet 1999; 354:10531060.
  • 15
    Angulo P, Jorgensen RA, Keach JC, Dickson ER, Smith C, Lindor KD. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 2000; 31:318323.
  • 16
    Hendrickse M, Rigney E, Giaffer MH, Soomro I, Triger DR, Underwood JC, Gleeson D. Low-dose methotrexate is ineffective in primary biliary cirrhosis: Long term results of a placebo-controlled trial. Gastroenterology 1999; 117:400407.